In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis.

The diuretic amiloride has been under recent investigation as adjunctive therapy for pulmonary disease in children with cystic fibrosis (CF). In preliminary studies, the antimicrobial activity of this agent alone or combined with beta-lactam agents against reference strains of Pseudomonas aeruginosa...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Cohn, R C, Jacobs, M, Aronoff, S C
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1988
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172183/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3364958/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.3.395
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!